Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin resistance.

Graeme J Hankey1, John W Eikelboom

  • 1Department of Neurology, Royal Perth Hospital and School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.

Lancet (London, England)
|February 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS).

International journal of stroke : official journal of the International Stroke Society·2021
Same author

Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.

Stroke·2021
Same author

Renal Impairment and Risk of Acute Stroke: The INTERSTROKE Study.

Neuroepidemiology·2021
Same author

Ischemic Events After Intracerebral Hemorrhage: A New Target for Secondary Prevention.

JAMA neurology·2021
Same author

Secondary Prevention of Stroke: Study Protocol for a Telehealth-Delivered Physical Activity and Diet Pilot Randomized Trial (ENAbLE-Pilot).

Cerebrovascular diseases (Basel, Switzerland)·2021
Same author

Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation.

International journal of molecular sciences·2021

Aspirin resistance, where aspirin fails to inhibit platelet activation, may increase cardiovascular event risk. Understanding its causes and detection is key to overcoming this condition.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Aspirin resistance is defined as aspirin's failure to adequately inhibit platelet thromboxane A2 production.
  • This resistance is linked to an increased risk of cardiovascular events.
  • Laboratory tests can detect aspirin resistance by assessing platelet thromboxane A2 production or function.

Purpose of the Study:

  • To explore the causes and implications of aspirin resistance.
  • To review methods for detecting aspirin resistance.
  • To discuss strategies for overcoming aspirin resistance.

Main Methods:

  • Literature review of studies on aspirin resistance.
  • Analysis of potential causes including inadequate dosage, drug interactions, and genetic factors.
  • Examination of diagnostic laboratory tests for platelet function.

Related Experiment Videos

Main Results:

  • Identified multiple causes of aspirin resistance: inadequate dosing, drug interactions, genetic variations (COX-1 polymorphisms), increased thromboxane production from non-platelet sources, and elevated platelet turnover.
  • Confirmed that aspirin resistance can be detected through specific laboratory assays.
  • Highlighted the correlation between increasing degrees of aspirin resistance and higher cardiovascular event risk.

Conclusions:

  • Aspirin resistance is a significant clinical issue associated with increased cardiovascular risk.
  • Addressing the underlying causes and utilizing appropriate diagnostic tests are crucial for managing aspirin resistance.
  • Future research should focus on refining definitions, improving diagnostic accuracy, and evaluating therapeutic interventions.